DOCSLIB.ORG

Diagnostic Test: GENODERMATOSI CARATTERIZZATE DA DISORDINI DI CHERATINIZZAZIONE / ITTIOSI EREDITARIA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnostic Test: GENODERMATOSI CARATTERIZZATE DA DISORDINI DI CHERATINIZZAZIONE / ITTIOSI EREDITARIA Diagnostic test: GENODERMATOSI CARATTERIZZATE DA DISORDINI DI CHERATINIZZAZIONE / ITTIOSI EREDITARIA GENODERMATOSIS CHARACTERIZED BY KERATINIZATION DISORDERS Panel / Illumina Custom panel, Nextera Enrichment Technology / Coding exons and flanking regions of genes List of gene(s) and disease(s) tested: ABCA12, ABHD5, ALDH3A2, ALOX12B, ALOXE3, AP1S1, AQP5, ATP2A2, ATP2C1, CDSN, CERS3, CLDN1, COL14A1, CSTA, CTSC, CYP4F22, DKC1, DSG1, DSP, EBP, ELOVL4, ENPP1, ERCC2, ERCC3, FLG, GJB2, GJB3, GJB4, GJB6, GTF2H5, JUP, KRT1, KRT10, KRT16, KRT17, KRT2, KRT6A, KRT6B, KRT9, LIPN, LOR, MBTPS2, MPLKIP, NHP2, NIPAL4, NOP10, NSDHL, PKP1, PNPLA1, POMP, RHBDF2, SAT1, SERPINB7, SLC27A4, SLURP1, SMARCAD1, SNAP29, SPINK5, ST14, STS, SUMF1, TAT, TERC, TERT, TGM1, TGM5, TINF2, WRAP53 Acrocheratosi verruciforme di Hopf Adermatoglifia congenita isolata Cheratoderma palmoplantare diffuso con fessure dolorose Cheratoderma palmoplantare epidermolitico Cheratoderma palmoplantare non epidermolitico Cheratoderma palmoplantare puntato, tipo 1 Cheratoderma palmoplantare transgrediens e progrediens Cheratoderma palmoplantare, tipo Nagashima Cheratosi follicolare spinulosa decalvante di Siemens Cheratosi lineare - ittiosi congenita - cheratoderma sclerosante Cheratosi palmoplantare striata Condrodisplasia puntata dominante legata all'X Deficit multiplo di solfatasi Discheratosi congenita Displasia ectodermica idrotica Eritrocheratodermia variabilis Ittiosi Ittiosi bollosa di Siemens Ittiosi esfoliativa Mal de Meleda Malattia di Darier Malattia di Naxos Pachionichia congenita Pemfigo benigno cronico familiare (Malattia di Hailey-Hailey) Sindrome BRESHECK Sindrome CEDNIK Sindrome cheratoderma palmoplantare-carcinoma esofageo Sindrome da desquamazione cutanea localizzata Sindrome di CHILD Sindrome di Dorfman-Chanarin Sindrome di Netherton Sindrome di Papillon-Lefèvre Sindrome di Richner-Hanhart (Tirosinemia, tipo 2) Sindrome di Sjögren-Larsson Sindrome di Sjögren-Larsson Sindrome displasia ectodermica-fragilità cutanea Sindrome ipopigmentazione-cheratoderma palmoplantare puntato (Malattia di Cole) Sindrome ittiosi-prematurità Sindrome KID/HID Sindrome MEDNIK sindrome NISCH Tricotiodistrofia Tabella. Elenco delle GENODERMATOSI CARATTERIZZATE DA DISORDINI DI CHERATINIZZAZIONE / ITTIOSI EREDITARIA e la loro eziologia genetica. Gene OMIM# Phenotype OMIM# Gene Phenotype ATP2A2 108740 Acrokeratosis verruciformis; Darier disease 101900; 124200 SMARCAD1 612761 Adermatoglyphia 136000 CERS3 615276 Autosomal recessive congenital ichthyosis 615023 SNAP29 604202 CEDNIK syndrome 609528 ABHD5 604780 Chanarin-Dorfman syndrome 275630 NSDHL 300275 CHILD syndrome 308050 EBP 300205 Chondrodysplasia punctata, X-linked dominant 302960 ENPP1 173335 Cole disease 615522 DKC1 300126 Dyskeratosis congenita 305000 TERC 602322 Dyskeratosis congenita, autosomal dominant 1 127550 TINF2 604319 Dyskeratosis congenita, autosomal dominant 3 613990 NOP10 606471 Dyskeratosis congenita, autosomal recessive 1 224230 NHP2 606470 Dyskeratosis congenita, autosomal recessive 2 613987 WRAP53 612661 Dyskeratosis congenita, autosomal recessive 3 613988 TERT 187270 Dyskeratosis congenita, autosomal recessive 4 613989 GJB6 604418 Ectodermal dysplasia, Clouston type 129500 PKP1 601975 Ectodermal dysplasia/skin fragility syndrome 604536 KRT9 607606 Epidermolytic palmoplantar keratoderma 144200 GJB3 603324 Erythrokeratodermia variabilis et progressiva 133200 GJB4 605425 Erythrokeratodermia variabilis with erythema gyratum repens 133200 CSTA 184600 Exfoliative ichthyosis 607936 ATP2C1 604384 Hailey-Hailey disease 169600 KRT2 600194 Ichthyosis bullosa of Siemens 146800 SLC27A4 604194 Ichthyosis prematurity syndrome 608649 FLG 135940 Ichthyosis vulgaris 146700 ST14 606797 Ichthyosis with hypotrichosis 610765 ABCA12 607800 Ichthyosis, autosomal recessive 4B (harlequin);Ichthyosis, congenital, autosomal 242500; 601277 recessive 4A TGM1 190195 Ichthyosis, congenital, autosomal recessive 1 242300 PNPLA1 612121 Ichthyosis, congenital, autosomal recessive 10 615024 ALOX12B 603741 Ichthyosis, congenital, autosomal recessive 2 242100 ALOXE3 607206 Ichthyosis, congenital, autosomal recessive 3 606545 CYP4F22 611495 Ichthyosis, congenital, autosomal recessive 5 604777 NIPAL4 609383 Ichthyosis, congenital, autosomal recessive 6 612281 LIPN 613924 Ichthyosis, congenital, autosomal recessive 8 613943 KRT1 139350 Ichthyosis, cyclic, with epidermolytic hyperkeratosis 607602 KRT10 148080 Ichthyosis, cyclic, with epidermolytic hyperkeratosis 607602 ELOVL4 605512 Ichthyosis, spastic quadriplegia and mental retardation 614457 STS 300747 Ichthyosis, X-linked 308100 CDSN 602593 Ichthyosis-hypotrichosis 146520 MBTPS2 300294 IFAP syndrome with or without BRESHECK syndrome 308205 CLDN1 603718 ILVASC 607626 COL14A1 120324 Keratoderma, palmoplantar, punctate type IB 614936 SAT1 313020 Keratosis follicularis spinulosa decalvans 308800 MBTPS2 300294 Keratosis follicularis spinulosa decalvans, X-linked 308800 POMP 613386 Keratosis linearis with ichthyosis congenita and sclerosing keratoderma 601952 GJB2 121011 KID syndrome 148210 SLURP1 606119 Mal de Meleda 248300 AP1S1 603531 MEDNIK syndrome 609313 SUMF1 607939 Multiple sulphatase deficiency 272200 JUP 173325 Naxos disease 601214 SPINK5 605010 Netherton syndrome 256500 KRT16 148067 Pachyonychia congenita type I (Jadassohn-Lewandowsky syndrome) 148067 KRT6A 148041 Pachyonychia congenita type I (Jadassohn-Lewandowsky syndrome) 167200 KRT17 148069 Pachyonychia congenita type II (Jackson-Lawler syndrome) 167210 KRT6B 148042 Pachyonychia congenita type II (Jackson-Lawler syndrome) 167210 AQP5 600442 Palmoplantar keratoderma, Bothnian type 600231 SERPINB7 603357 Palmoplantar keratosis, Nagashima type 615598 CTSC 602365 Papillon-Lefèvre syndrome 245000 TGM5 603805 Peeling skin syndrome, acral type 609796 TAT 613018 Richner-Hanhart syndrome, tyrosinaemia, type II 276600 ALDH3A2 609523 Sjögren-Larsson syndrome 270200 DSG1 125670 Striate palmoplantar keratoderma (PPKS1) 148700 DSP 125647 Striate palmoplantar keratoderma (PPKS2) 612908 ERCC2 126340 Trichothiodystrophy 601675 ERCC3 133510 Trichothiodystrophy 601675 GTF2H5 608780 Trichothiodystrophy 601675 MPLKIP 609188 Trichothiodystrophy, non-photosensitive 1 234050 RHBDF2 614404 Tylosis with oesophageal cancer 148500 LOR 152445 Vohwinkel syndrome (ichthyotic variant) 604117 MEDNIK = mental retardation, enteropathy, deafness, neuropathy, ichthyosis and keratoderma; ILVASC = ichthyosis, leucocyte vacuoles, alopecia and sclerosing cholangitis; KID = ker- atitis, ichthyosis and tion, ectodermal dysplasia, skeletal malformations, Hirschsprungdeafness; IFAP = ichthyosis follicularis, alo- pecia and photophobia; BRESHECK = brain anomalies, retarda-disease, ear/eye anomalies, cleft palate/cryptorchidism and kidney dysplasia/hypoplasia; CHILD = congenital hemidysplasia with ichthyosiform erythroderma and limb defects; CEDNIK = cerebral dysgenesis, neuropathy, ichthyosis and keratoderma. .
Load more

Recommended publications
  • Inherited Bone Marrow Failure Syndrome (IBMFS) Testing
    Lab Management Guidelines V2.0.2021 Inherited Bone Marrow Failure Syndrome (IBMFS) Testing MOL.TS.360.A v2.0.2021 Introduction Inherited bone marrow failure syndrome (IBMFS) genetic testing is addressed by this guideline. Procedures addressed The inclusion of any procedure code in this table does not imply that the code is under management or requires prior authorization. Refer to the specific Health Plan's procedure code list for management requirements. Procedures addressed by this Procedure codes guideline IBMFS Multigene panel 81479 What are inherited bone marrow failure syndromes Definition Bone marrow failure (BMF) is the inability of the bone marrow to produce a sufficient quantity of functional blood cells to meet physiologic demands.1 BMF is typically classified into three categories, based on presumed etiology: inherited, secondary, or idiopathic.1 Inherited bone marrow failure syndromes (IBMFSs) are a group of genetically defined disorders that are characterized by BMF. Individuals presenting with aplastic anemia (AA), myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and chronic unexplained cytopenias should be evaluated for an IBMFS.1 Incidence "The incidence of inherited bone marrow failures accounts for 10% to 15% of marrow aplasia and 30% of pediatric bone marrow failure disorders with approximately 65 cases per million live births every year."2 Seventy-five percent of children with an IBMFS have an identifiable cause.2 ©2021 eviCore healthcare. All Rights Reserved. 1 of 17 400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924 www.eviCore.com Lab Management Guidelines V2.0.2021 Symptoms While specific features may vary by each type of IBMFS, features that are present in most IBMFSs include bone marrow failure with single or multi-lineage cytopenia.
    [Show full text]
  • Open Full Page
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders Michael F. Walsh1, Vivian Y. Chang2, Wendy K. Kohlmann3, Hamish S. Scott4, Christopher Cunniff5, Franck Bourdeaut6, Jan J. Molenaar7, Christopher C. Porter8, John T. Sandlund9, Sharon E. Plon10, Lisa L. Wang10, and Sharon A. Savage11 Abstract DNA repair syndromes are heterogeneous disorders caused by around the world to discuss and develop cancer surveillance pathogenic variants in genes encoding proteins key in DNA guidelines for children with cancer-prone disorders. Herein, replication and/or the cellular response to DNA damage. The we focus on the more common of the rare DNA repair dis- majority of these syndromes are inherited in an autosomal- orders: ataxia telangiectasia, Bloom syndrome, Fanconi ane- recessive manner, but autosomal-dominant and X-linked reces- mia, dyskeratosis congenita, Nijmegen breakage syndrome, sive disorders also exist. The clinical features of patients with DNA Rothmund–Thomson syndrome, and Xeroderma pigmento- repair syndromes are highly varied and dependent on the under- sum. Dedicated syndrome registries and a combination of lying genetic cause. Notably, all patients have elevated risks of basic science and clinical research have led to important in- syndrome-associated cancers, and many of these cancers present sights into the underlying biology of these disorders. Given the in childhood. Although it is clear that the risk of cancer is rarity of these disorders, it is recommended that centralized increased, there are limited data defining the true incidence of centers of excellence be involved directly or through consulta- cancer and almost no evidence-based approaches to cancer tion in caring for patients with heritable DNA repair syn- surveillance in patients with DNA repair disorders.
    [Show full text]
  • My Beloved Neutrophil Dr Boxer 2014 Neutropenia Family Conference
    The Beloved Neutrophil: Its Function in Health and Disease Stem Cell Multipotent Progenitor Myeloid Lymphoid CMP IL-3, SCF, GM-CSF CLP Committed Progenitor MEP GMP GM-CSF, IL-3, SCF EPO TPO G-CSF M-CSF IL-5 IL-3 SCF RBC Platelet Neutrophil Monocyte/ Basophil B-cells Macrophage Eosinophil T-Cells Mast cell NK cells Mature Cell Dendritic cells PRODUCTION AND KINETICS OF NEUTROPHILS CELLS % CELLS TIME Bone Marrow: Myeloblast 1 7 - 9 Mitotic Promyelocyte 4 Days Myelocyte 16 Maturation/ Metamyelocyte 22 3 – 7 Storage Band 30 Days Seg 21 Vascular: Peripheral Blood Seg 2 6 – 12 hours 3 Marginating Pool Apoptosis and ? Tissue clearance by 0 – 3 macrophages days PHAGOCYTOSIS 1. Mobilization 2. Chemotaxis 3. Recognition (Opsonization) 4. Ingestion 5. Degranulation 6. Peroxidation 7. Killing and Digestion 8. Net formation Adhesion: β 2 Integrins ▪ Heterodimer of a and b chain ▪ Tight adhesion, migration, ingestion, co- stimulation of other PMN responses LFA-1 Mac-1 (CR3) p150,95 a2b2 a CD11a CD11b CD11c CD11d b CD18 CD18 CD18 CD18 Cells All PMN, Dendritic Mac, mono, leukocytes mono/mac, PMN, T cell LGL Ligands ICAMs ICAM-1 C3bi, ICAM-3, C3bi other other Fibrinogen other GRANULOCYTE CHEMOATTRACTANTS Chemoattractants Source Activators Lipids PAF Neutrophils C5a, LPS, FMLP Endothelium LTB4 Neutrophils FMLP, C5a, LPS Chemokines (a) IL-8 Monocytes, endothelium LPS, IL-1, TNF, IL-3 other cells Gro a, b, g Monocytes, endothelium IL-1, TNF other cells NAP-2 Activated platelets Platelet activation Others FMLP Bacteria C5a Activation of complement Other Important Receptors on PMNs ñ Pattern recognition receptors – Detect microbes - Toll receptor family - Mannose receptor - bGlucan receptor – fungal cell walls ñ Cytokine receptors – enhance PMN function - G-CSF, GM-CSF - TNF Receptor ñ Opsonin receptors – trigger phagocytosis - FcgRI, II, III - Complement receptors – ñ Mac1/CR3 (CD11b/CD18) – C3bi ñ CR-1 – C3b, C4b, C3bi, C1q, Mannose binding protein From JG Hirsch, J Exp Med 116:827, 1962, with permission.
    [Show full text]
  • Genetic Features of Myelodysplastic Syndrome and Aplastic Anemia in Pediatric and Young Adult Patients
    Bone Marrow Failure SUPPLEMENTARY APPENDIX Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients Siobán B. Keel, 1* Angela Scott, 2,3,4 * Marilyn Sanchez-Bonilla, 5 Phoenix A. Ho, 2,3,4 Suleyman Gulsuner, 6 Colin C. Pritchard, 7 Janis L. Abkowitz, 1 Mary-Claire King, 6 Tom Walsh, 6** and Akiko Shimamura 5** 1Department of Medicine, Division of Hematology, University of Washington, Seattle, WA; 2Clinical Research Division, Fred Hutchinson Can - cer Research Center, Seattle, WA; 3Department of Pediatric Hematology/Oncology, Seattle Children’s Hospital, WA; 4Department of Pedi - atrics, University of Washington, Seattle, WA; 5Boston Children’s Hospital, Dana Farber Cancer Institute, and Harvard Medical School, MA; 6Department of Medicine and Department of Genome Sciences, University of Washington, Seattle, WA; and 7Department of Laboratory Medicine, University of Washington, Seattle, WA, USA *SBK and ASc contributed equally to this work **TW and ASh are co-senior authors ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2016.149476 Received: May 16, 2016. Accepted: July 13, 2016. Pre-published: July 14, 2016. Correspondence: [email protected] or [email protected] Supplementary materials Supplementary methods Retrospective chart review Patient data were collected from medical records by two investigators blinded to the results of genetic testing. The following information was collected: date of birth, transplant, death, and last follow-up,
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Trichothiodystrophy
    Trichothiodystrophy Author: Doctor Alfredo Rossi1 and Doctor C. Cantisani. Creation date: June 2004 Scientific Editor: Prof Antonella Tosti 1Dipartimento di Malattie Cutanee-Veneree Chirurgia Plastica-Ricostruttiva, Università degli studi di Roma “La Sapienza” Abstract Keywords Definition Epidemiology Etiology Clinical description Diagnostic methods Prenatal diagnosis Management References Abstract Trichothiodystrophy (TTD) is a rare autosomal recessive genetic disorder characterized by abnormal synthesis of the sulphur containing keratins and consequently hair dysplasia, associated with numerous symptoms affecting mainly organs derived from the neuroectoderm. This phenotypic aspect is due to mutations in the DNA-dependent ATPase/helicase subunit of TFIIH, XPB and XPD. Abnormalities in excision repair of ultraviolet (UV)-damaged DNA are recognized in about half of the patients. The clinical appearance is characterized by brittle and fragile hair, congenital ichthyosis, nail and dental dysplasias, cataract, progeria-like face, growth and mental retardation. The abnormalities are usually obvious at birth, with variable clinical expression. The variants of TTD, depending on their different associations, are known by the initials BIDS, IBIDS, PIBIDS, SIBIDS, ONMRS, as well as the eponyms of the Pollit, Tay, Sabinas syndromes or Amish brittle hair. The exact prevalence of TTD is unknown, but appears to be rather uncommon. About 20 cases of PIBI(D)S have been reported in the literature. Up to 1991, clinical data of 15 cases with IBIDS were published. Prenatal diagnostic of TTD is available. There is no specific treatment. Keywords Brittle hair, photosensitivity, ichthyosis, BIDS, IBIDS, PIBIDS, SIBIDS, ONMRS, Tay-syndrome Definition tail pattern). They named it Trichothiodystrophy, Trichothiodystrophy (TTD) is a group of rare noticing also an increased Photosensitivity and autosomal recessive disorders with heterogenic Ichthyosis in these patients (PIBIDS).
    [Show full text]
  • The Genetics and Clinical Manifestations of Telomere Biology Disorders Sharon A
    REVIEW The genetics and clinical manifestations of telomere biology disorders Sharon A. Savage, MD1, and Alison A. Bertuch, MD, PhD2 3 Abstract: Telomere biology disorders are a complex set of illnesses meric sequence is lost with each round of DNA replication. defined by the presence of very short telomeres. Individuals with classic Consequently, telomeres shorten with aging. In peripheral dyskeratosis congenita have the most severe phenotype, characterized blood leukocytes, the cells most extensively studied, the rate 4 by the triad of nail dystrophy, abnormal skin pigmentation, and oral of attrition is greatest during the first year of life. Thereafter, leukoplakia. More significantly, these individuals are at very high risk telomeres shorten more gradually. When the extent of telo- of bone marrow failure, cancer, and pulmonary fibrosis. A mutation in meric DNA loss exceeds a critical threshold, a robust anti- one of six different telomere biology genes can be identified in 50–60% proliferative signal is triggered, leading to cellular senes- of these individuals. DKC1, TERC, TERT, NOP10, and NHP2 encode cence or apoptosis. Thus, telomere attrition is thought to 1 components of telomerase or a telomerase-associated factor and TINF2, contribute to aging phenotypes. 5 a telomeric protein. Progressively shorter telomeres are inherited from With the 1985 discovery of telomerase, the enzyme that ex- generation to generation in autosomal dominant dyskeratosis congenita, tends telomeric nucleotide repeats, there has been rapid progress resulting in disease anticipation. Up to 10% of individuals with apparently both in our understanding of basic telomere biology and the con- acquired aplastic anemia or idiopathic pulmonary fibrosis also have short nection of telomere biology to human disease.
    [Show full text]
  • Dyskeratosis Congenita 101
    Dyskeratosis Congenita 101 Sharon A. Savage, M.D. Chief, Clinical Genetics Branch Clinical Director, Division of Cancer Epidemiology & Genetics Camp Sunshine September 2018 2012 2016 Dyskeratosis Congenita – early descriptions Year Author(s) Reference Atrophia Cutis Reticularis cum Pigmentatione, Dystrophia 1906 Zinsser, F Unguium et Leukoplakia oris, Ikonogr Derm (Kioto), p 219 A Unique Case of Reticular Pigmentation of the Skin with 1910 Engman, MF, Sr Atrophy, Society Transactions, Arch Derm Syph 13:685 Cole, HN, Dyskeratosis Congenita with Pigmentation, Dystrophia 1930 Rauschkolb JE, Unguis, and Leukokeratosis Oris, Arch Derm Syph 21:71 and Toomey J Archives of Dermatology Vol 88, Sept. 1963 People with telomere biology disorders may face multiple medical problems and always Remember: Ø Everyone is different Ø These problems don’t happen to everyone Ø Things change with age Ø We learn more everyday Diagnostic Triad 1. Dysplastic Nails Diagnostic Triad 2. Skin pigmentation Diagnostic Triad 3. Oral leukoplakia Hematopoietic (blood) system Bone marrow failure Failure to produce enough blood cells Myelodysplastic syndrome Abnormal looking blood cells associated with low numbers and leukemia risk Leukemia Cancer of the blood forming cells Respiratory system Head and neck squamous cell cancer Pulmonary fibrosis Pulmonary arterio- venous malformations (AVMs) Abnormal blood vessel formation in lungs Gastrointestinal (GI) system Esophageal stenosis Liver disease Narrowing of the esophagus Fibrosis and/or abnormal blood vessel connections between
    [Show full text]
  • Hereditary Hearing Impairment with Cutaneous Abnormalities
    G C A T T A C G G C A T genes Review Hereditary Hearing Impairment with Cutaneous Abnormalities Tung-Lin Lee 1 , Pei-Hsuan Lin 2,3, Pei-Lung Chen 3,4,5,6 , Jin-Bon Hong 4,7,* and Chen-Chi Wu 2,3,5,8,* 1 Department of Medical Education, National Taiwan University Hospital, Taipei City 100, Taiwan; [email protected] 2 Department of Otolaryngology, National Taiwan University Hospital, Taipei 11556, Taiwan; [email protected] 3 Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei City 100, Taiwan; [email protected] 4 Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei City 100, Taiwan 5 Department of Medical Genetics, National Taiwan University Hospital, Taipei 10041, Taiwan 6 Department of Internal Medicine, National Taiwan University Hospital, Taipei 10041, Taiwan 7 Department of Dermatology, National Taiwan University Hospital, Taipei City 100, Taiwan 8 Department of Medical Research, National Taiwan University Biomedical Park Hospital, Hsinchu City 300, Taiwan * Correspondence: [email protected] (J.-B.H.); [email protected] (C.-C.W.) Abstract: Syndromic hereditary hearing impairment (HHI) is a clinically and etiologically diverse condition that has a profound influence on affected individuals and their families. As cutaneous findings are more apparent than hearing-related symptoms to clinicians and, more importantly, to caregivers of affected infants and young individuals, establishing a correlation map of skin manifestations and their underlying genetic causes is key to early identification and diagnosis of syndromic HHI. In this article, we performed a comprehensive PubMed database search on syndromic HHI with cutaneous abnormalities, and reviewed a total of 260 relevant publications.
    [Show full text]
  • Pediatric Photosensitivity Disorders Dr
    FAST FACTS FOR BOARD REVIEW Series Editor: William W. Huang,MD,MPH W. Series Editor:William Swetha N.Pathak,MD;JacquelineDeLuca,MD Pediatric PhotosensitivityDisorders Table 1. Pediatric Photosensitivity Disorders Disease Pathophysiology Clinical Features Management/Prognosis Other/Pearls Actinic prurigo Strong association Pruritic crusted papules Phototesting: lesions Native Americans, (hydroa aestivale, with HLA-DR4 and nodules in both provoked by UVA or UVB; especially mestizos; Hutchinson (HLA-DRB1*0401/0407); sun-exposed and less spontaneous resolution hardening does not summer prurigo) may be a persistent frequently nonexposed may occur during late occur; histopathology: variant of PMLE sites (ie, buttocks); heal adolescence; may follow dermal perivascular (delayed-type with scarring; mucosal a chronic course that mononuclear cell hypersensitivity) and conjunctival persists in adulthood; infiltrate, lacks papillary from UVA or UVB involvement, with cheilitis photoprotection; topical dermal edema, can see often an initial or only corticosteroids and lymphoid follicles feature; worse in summer topical tacrolimus; from lip biopsies; but can extend to winter NB-UVB or PUVA; occurs hours to cyclosporine or days following azathioprine; thalidomide sun exposure (treatment of choice) for (vs solar urticaria) resistant disease noconflictofinterest. The authorsreport Long Beach,California. Center, LaserSkinCare DeLucaisfrom Dr. North Carolina. Winston-Salem, University, Forest Wake Pathakisfrom Dr. Bloom syndrome AR; BLM (encodes Malar telangiectatic
    [Show full text]
  • Pili Torti: a Feature of Numerous Congenital and Acquired Conditions
    Journal of Clinical Medicine Review Pili Torti: A Feature of Numerous Congenital and Acquired Conditions Aleksandra Hoffmann 1 , Anna Wa´skiel-Burnat 1,*, Jakub Z˙ ółkiewicz 1 , Leszek Blicharz 1, Adriana Rakowska 1, Mohamad Goldust 2 , Małgorzata Olszewska 1 and Lidia Rudnicka 1 1 Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland; [email protected] (A.H.); [email protected] (J.Z.);˙ [email protected] (L.B.); [email protected] (A.R.); [email protected] (M.O.); [email protected] (L.R.) 2 Department of Dermatology, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5021-324; Fax: +48-22-824-2200 Abstract: Pili torti is a rare condition characterized by the presence of the hair shaft, which is flattened at irregular intervals and twisted 180◦ along its long axis. It is a form of hair shaft disorder with increased fragility. The condition is classified into inherited and acquired. Inherited forms may be either isolated or associated with numerous genetic diseases or syndromes (e.g., Menkes disease, Björnstad syndrome, Netherton syndrome, and Bazex-Dupré-Christol syndrome). Moreover, pili torti may be a feature of various ectodermal dysplasias (such as Rapp-Hodgkin syndrome and Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome). Acquired pili torti was described in numerous forms of alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, dissecting Citation: Hoffmann, A.; cellulitis, folliculitis decalvans, alopecia areata) as well as neoplastic and systemic diseases (such Wa´skiel-Burnat,A.; Zółkiewicz,˙ J.; as cutaneous T-cell lymphoma, scalp metastasis of breast cancer, anorexia nervosa, malnutrition, Blicharz, L.; Rakowska, A.; Goldust, M.; Olszewska, M.; Rudnicka, L.
    [Show full text]
  • Familial Congenital Generalized Hypertrichosis, Which Laser Treatment
    Net Letter FFamilialamilial ccongenitalongenital ggeneralizedeneralized hypertrichosishypertrichosis Sir, Hair on chest and abdomen was sparse. There was Hypertrichosis is defined as an abnormal hair no hair on palms, soles and mucosal surfaces. Both growth resulting in an increase in body hair beyond breasts were normal and there was no clitoromegaly. the normal variation for a patient’s reference group; There were no associated dental anomalies, facial excluding androgen-induced hair growth. This should dysmorphism or gingival hyperplasia. Hormone be differentiated from hirsutism, which is increased levels were within range (Luteinizing Hormone hair growth in androgen dependent areas.[1] It is 4 IU/L, Follicle Stimulating Hormone 3.5 IU/L, usually a cosmetic problem, but may be associated Estradiol 54 pg/ml, Thyroid-Stimulating Hormone. with an underlying disorder that requires further 2.2 IU/ml and testosterone 0.9 ng/ml). Uterus and investigation. It has been classified into congenital and ovaries were normal on ultrasound. A diagnosis of acquired with further subdivision into generalized or congenital generalized familial hypertrichosis was localized hypertrichosis.[2] We present a rare case of made. Patient was counseled and referred for full body familial congenital generalized hypertrichosis, which laser treatment. However as she could not afford the on literature search has been reported in very few treatment, she continued with shaving and waxing. families worldwide. Congenital generalized hypertrichosis has terminal An 18-year-old girl, presented with profuse hair growth hair with typical phenotypic characteristics as over face, arms, legs and back since birth. Her thelarche described in our patient and has an autosomal or and menarche were normal and menstrual cycles were X-linked dominant pattern of inheritance, which regular with normal flow.
    [Show full text]